EUVIMEDScopri EUVIMED
Open access · CC BY 4.0

Mesenchymal Stem Cell Membrane‐Derived Composite System for Enhancing the Tumor Treatment Efficacy of Metal–Organic Framework Nanoparticles

Ying Tong iD, Meng Gao iD, Yingli Luo iD

IET Nanobiotechnology · 2024-01 · 2024 (1)

DOI: 10.1049/nbt2/1069307 ↗

At a glance

Journal article in IET Nanobiotechnology, published online on 2024-12-04. Written by Ying Tong and 2 co-authors. Institution: Wuxi School of Medicine, Jiangnan University, Wuxi 214122, Jiangsu, China. Major MEDLINE topics: Metal-Organic Frameworks, Mesenchymal Stem Cells, Copper. Cited 5 times so far (Crossref); 22 references. The full text is freely available (open access, CC BY 4.0). Funded by: Fundamental Research Funds for the Central Universities.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Mesenchymal stem cell (MSC) membrane‐coated metal–organic frameworks (MOFs) represent an innovative approach to enhance the uptake and therapeutic efficacy of copper‐based MOFs (Cu‐MOFs) in tumor cells. By leveraging the natural homing abilities and biocompatibility of MSC membranes, Cu‐MOFs can be effectively targeted to tumor sites, promoting increased cellular uptake. This coating not only facilitates superior internalization by cancer cells but also augments the therapeutic outcomes due to the enhanced delivery of copper ions. In vitro studies demonstrate that MSC membrane‐coated Cu‐MOFs (MSC‐Cu‐MOFs) significantly improve the cytotoxic effects on tumor cells compared to uncoated Cu‐MOFs. This novel strategy presents a promising avenue for advancing the precision and effectiveness of cancer treatment modalities, showcasing potential for clinical applications in oncology.

Subjects

MeSH terms (MEDLINE)

Metal-Organic FrameworksMesenchymal Stem CellsCopperHumansAntineoplastic AgentsCell MembraneCell Line, TumorCell SurvivalAnimalsNeoplasms

Author keywords

cytotoxic effectsmesenchymal stem cellmetal-organic frameworkstumor treatment

Substances

Metal-Organic FrameworksCopperAntineoplastic Agents

Authors and institutions

  • Wuxi School of Medicine, Jiangnan University, Wuxi 214122, Jiangsu, China.
  • State Key Laboratory of Food Science and Technology, Jiangnan University, Wuxi 214122, China.
  • Department of Gastroenterology, The Second People's Hospital of Hefei, Hefei Hospital Affiliated to Anhui Medical University, Hefei 230011, Anhui, China.

ORCID profiles: Ying Tong, Meng Gao, Yingli Luo

Funding

  • Fundamental Research Funds for the Central Universities

Cite

APA

Tong, Y., Gao, M., & Luo, Y. (2024). Mesenchymal Stem Cell Membrane‐Derived Composite System for Enhancing the Tumor Treatment Efficacy of Metal–Organic Framework Nanoparticles. IET Nanobiotechnology, 2024(1). https://doi.org/10.1049/nbt2/1069307

Vancouver

Tong Y, Gao M, Luo Y. Mesenchymal Stem Cell Membrane‐Derived Composite System for Enhancing the Tumor Treatment Efficacy of Metal–Organic Framework Nanoparticles. IET Nanobiotechnology. 2024;2024(1). doi:10.1049/nbt2/1069307

BibTeX
@article{Tong2024,
  author = {Tong, Ying and Gao, Meng and Luo, Yingli},
  title = {Mesenchymal Stem Cell Membrane‐Derived Composite System for Enhancing the Tumor Treatment Efficacy of Metal–Organic Framework Nanoparticles},
  journal = {IET Nanobiotechnology},
  year = {2024},
  volume = {2024},
  number = {1},
  doi = {10.1049/nbt2/1069307}
}
Start for free →